Mengis Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.44M |
| 2 |
Merck
MRK
|
+$664K |
| 3 |
Target
TGT
|
+$593K |
| 4 |
Qualcomm
QCOM
|
+$435K |
| 5 |
GE Aerospace
GE
|
+$409K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Northwest Natural Holdings
NWN
|
+$661K |
| 2 |
Baxter International
BAX
|
+$431K |
| 3 |
Intel
INTC
|
+$322K |
| 4 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$313K |
| 5 |
NTI
NORTHERN TIER ENERGY LP CLASS A
NTI
|
+$259K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.47% |
| 2 | Healthcare | 14.25% |
| 3 | Energy | 10.53% |
| 4 | Financials | 9.72% |
| 5 | Consumer Staples | 9.54% |
Similar funds
Mengis Capital Management's Q2 2016 Portfolio in Review
As of Q2 2016, Mengis Capital Management held 109 positions worth $113M, up 4.8% from $108M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Mengis Capital Management deployed $3.72M of net new capital in Q2 2016, opening 6 new positions and adding to 47 existing holdings. Its largest new stake was Allergan Inc: 6,210 shares worth $1.44M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Energy.
On the sell side, the largest reduction was Northwest Natural Holdings, an estimated $661K trimmed.
- Mengis Capital Management's largest Q2 2016 buy was Allergan Inc: 6,210 shares worth $1.44M.
- Mengis Capital Management added most to Merck in Q2 2016, an estimated $664K increase.
- Mengis Capital Management's biggest Q2 2016 reduction was Northwest Natural Holdings, cutting an estimated $661K.
- Mengis Capital Management fully exited Baxter International in Q2 2016, selling an estimated $431K.
- Mengis Capital Management's ten largest holdings make up 30% of its $113M portfolio in Q2 2016.
- Mengis Capital Management opened 6 new positions and closed 5 in Q2 2016.
- Mengis Capital Management's portfolio value rose 4.8% quarter-over-quarter to $113M.
Based on Mengis Capital Management's 13F filing for Q2 2016, filed 8 Aug 2016.